Aperio Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $539K | Sell |
7,344
-582
| -7% | -$42.7K | ﹤0.01% | 1934 |
|
|
2020
Q3 | $435K | Sell |
7,926
-2,881
| -27% | -$158K | ﹤0.01% | 1886 |
|
|
2020
Q2 | $719K | Sell |
10,807
-3,405
| -24% | -$227K | ﹤0.01% | 1578 |
|
|
2020
Q1 | $870K | Buy |
14,212
+4,932
| +53% | +$302K | ﹤0.01% | 1369 |
|
|
2019
Q4 | $816K | Sell |
9,280
-7,842
| -46% | -$690K | ﹤0.01% | 1546 |
|
|
2019
Q3 | $1.29M | Sell |
17,122
-828
| -5% | -$62.5K | 0.01% | 1264 |
|
|
2019
Q2 | $1.53M | Sell |
17,950
-99
| -0.5% | -$8.46K | 0.01% | 1194 |
|
|
2019
Q1 | $1.95M | Sell |
18,049
-1,331
| -7% | -$144K | 0.01% | 1048 |
|
|
2018
Q4 | $1.64M | Sell |
19,380
-2,517
| -11% | -$213K | 0.01% | 1066 |
|
|
2018
Q3 | $2.15M | Buy |
21,897
+2,631
| +14% | +$259K | 0.01% | 1030 |
|
|
2018
Q2 | $2.23M | Sell |
19,266
-6,757
| -26% | -$782K | 0.01% | 980 |
|
|
2018
Q1 | $2.57M | Sell |
26,023
-29,243
| -53% | -$2.89M | 0.01% | 893 |
|
|
2017
Q4 | $5.79M | Buy |
55,266
+3,300
| +6% | +$346K | 0.03% | 586 |
|
|
2017
Q3 | $5.86M | Buy |
51,966
+1,140
| +2% | +$128K | 0.03% | 549 |
|
|
2017
Q2 | $5.7M | Buy |
50,826
+16,233
| +47% | +$1.82M | 0.03% | 538 |
|
|
2017
Q1 | $4.03M | Buy |
34,593
+14,746
| +74% | +$1.72M | 0.03% | 633 |
|
|
2016
Q4 | $2.09M | Sell |
19,847
-27,219
| -58% | -$2.86M | 0.02% | 806 |
|
|
2016
Q3 | $5.2M | Sell |
47,066
-3,954
| -8% | -$437K | 0.04% | 521 |
|
|
2016
Q2 | $7.43M | Buy |
51,020
+42,632
| +508% | +$6.21M | 0.06% | 373 |
|
|
2016
Q1 | $1.2M | Buy |
8,388
+6,421
| +326% | +$920K | 0.01% | 963 |
|
|
2015
Q4 | $304K | Buy |
+1,967
| New | +$304K | ﹤0.01% | 1615 |
|